With links on voodoo ROI, enzymatic scaling laws, ex post lobbying, malicious drug discovery, and more.
Share this post
March 2022 SubCriticalAppraisal Newsletter
Share this post
With links on voodoo ROI, enzymatic scaling laws, ex post lobbying, malicious drug discovery, and more.